Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
The TikTok generation are becoming “renegade” investors
5th Sep 2024
The Monthly: September 2024
2nd Sep 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
102: EIS is 30! Discussing the past, present and future of the scheme | Christiana Stewart-Lockhart of the EIS Association
Stay up-to-date with the latest research
Sign up to our newsletter
Podcast
All
Events
In the media
Insight
MiFID II Monitor
News
Podcast
Tax Advantaged
Video
Select a department
Events
In the media
Insight
MiFID II Monitor
News
Podcast
Tax Advantaged
Video
79: The anatomy of busts: comparing the VC market across three cycles | Kealan...
25 Jul 2023
|
By Dr Brian...
Bonus episode 78: Investor confidence and ESG: how the new disclosure rules will drive...
18 Jul 2023
|
By Dr Brian...
78: How ESG rule changes will make investors happier | Lee Coates of ESG...
11 Jul 2023
|
By Dr Brian...
77: Life science is not just drugs | Savvas Neophytou and Ben Carter of...
06 Jun 2023
|
By Dr Brian...
76: How venture debt works | David Hayers of Hambro Perks
16 May 2023
|
By Dr Brian...
75: Fundraising market from equity crowdfunding to Series B | Antonia Burridge and John...
02 May 2023
|
By Dr Brian...
74: Making GP/LP venture capital funds accessible to retail investors | Jonny Blausten of...
18 Apr 2023
|
By Dr Brian...
73: Patterns in venture capital exits | Henry Whorwood of Beauhurst
04 Apr 2023
|
By Dr Brian...
72: What happened at Silicon Valley Bank and its effect on UK venture capital...
21 Mar 2023
|
By Dr Brian...
71: Why agritech’s time has come | Paul Rous of Regenerate Ventures
07 Mar 2023
|
By Dr Brian...
70: The challenges and successes of supporting companies after investment | Ben Leslie of...
21 Feb 2023
|
By Dr Brian...
69: Why venture building will become more important, controlled experiments and fixing EIS |...
07 Feb 2023
|
By Dr Brian...
Prev
1
2
3
4
5
...
10
Next